"Mefloquine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A phospholipid-interacting antimalarial drug (ANTIMALARIALS). It is very effective against PLASMODIUM FALCIPARUM with very few side effects.
Descriptor ID |
D015767
|
MeSH Number(s) |
D03.633.100.810.410
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Mefloquine".
Below are MeSH descriptors whose meaning is more specific than "Mefloquine".
This graph shows the total number of publications written about "Mefloquine" by people in this website by year, and whether "Mefloquine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2002 | 0 | 1 | 1 |
2004 | 0 | 1 | 1 |
2006 | 1 | 0 | 1 |
2010 | 1 | 0 | 1 |
2012 | 0 | 1 | 1 |
2015 | 1 | 0 | 1 |
2016 | 1 | 0 | 1 |
2017 | 0 | 2 | 2 |
2018 | 0 | 2 | 2 |
2020 | 1 | 0 | 1 |
2021 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Mefloquine" by people in Profiles.
-
A SARS-CoV-2 cytopathicity dataset generated by high-content screening of a large drug repurposing collection. Sci Data. 2021 02 26; 8(1):70.
-
Antimalarial artemisinin-based combination therapies (ACT) and COVID-19 in Africa: In vitro inhibition of SARS-CoV-2 replication by mefloquine-artesunate. Int J Infect Dis. 2020 Oct; 99:437-440.
-
The Plasmodium falciparum cytoplasmic translation apparatus: a promising therapeutic target not yet exploited by clinically approved anti-malarials. Malar J. 2018 Dec 12; 17(1):465.
-
Prediction Model for Antimalarial Activities of Hemozoin Inhibitors by Using Physicochemical Properties. Antimicrob Agents Chemother. 2018 05; 62(5).
-
Response to Letter to the Editor: Confounding by Symptomatic Mefloquine Exposure in Military Studies of Post-Traumatic Stress Disorder. Behav Med. 2018 Apr-Jun; 44(2):173-174.
-
Partner-Drug Resistance and Population Substructuring of Artemisinin-Resistant Plasmodium falciparum in Cambodia. Genome Biol Evol. 2017 06 01; 9(6):1673-1686.
-
2,8-bis(trifluoromethyl)quinoline analogs show improved anti-Zika virus activity, compared to mefloquine. Eur J Med Chem. 2017 Feb 15; 127:334-340.
-
Evaluation of intermittent preventive treatment of malaria against group B Streptococcus colonization in pregnant women: a nested analysis of a randomized controlled clinical trial of sulfadoxine/pyrimethamine versus mefloquine. J Antimicrob Chemother. 2015; 70(6):1898-902.
-
Effect of single nucleotide polymorphisms in cytochrome P450 isoenzyme and N-acetyltransferase 2 genes on the metabolism of artemisinin-based combination therapies in malaria patients from Cambodia and Tanzania. Antimicrob Agents Chemother. 2013 Feb; 57(2):950-8.
-
Cost-effectiveness analysis of malaria chemoprophylaxis for travellers to West-Africa. BMC Infect Dis. 2010 Sep 22; 10:279.